Exogenous interleukin-33 targets myeloid-derived suppressor cells and generates periphery-induced Foxp3+ regulatory T cells in skin-transplanted mice

Immunology

Volumn 146, Issue 1, 2015, Pages 81-88

  Gajardo, Tania ^a,b   Morales, Rodrigo A ^b   Campos Mora, Mauricio ^a,b   Campos Acuña, Javier ^b   Pino Lagos, Karina ^a,b  

^a UNIVERSIDAD DE LOS ANDES   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

Foxp3+ regulatory T cells; Interleukin 33; Tolerance; Transplantation

Indexed keywords

ARGINASE 1; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 33; TRANSCRIPTION FACTOR FOXP3; ARG1 PROTEIN, MOUSE; ARGINASE; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; HLA ANTIGEN CLASS 2; IL10 PROTEIN, MOUSE; IL33 PROTEIN, MOUSE; INTERLEUKIN DERIVATIVE;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CELL COUNT; CELL EXPANSION; CELLULAR IMMUNITY; CLINICAL EVALUATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EX VIVO STUDY; GENE EXPRESSION; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOMODULATION; IN VIVO STUDY; LYMPH NODE; MOUSE; MYELOID DERIVED SUPPRESSOR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; REGULATORY T LYMPHOCYTE; SKIN ALLOGRAFT; SUPPRESSOR CELL; TH1 CELL; TH17 CELL; UPREGULATION; WILD TYPE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECTS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; ISOGRAFT; LYMPHOCYTE ACTIVATION; SECRETION (PROCESS); SKIN; SKIN TRANSPLANTATION;

ANIMALS; ARGINASE; CELL DIFFERENTIATION; CELL PROLIFERATION; FORKHEAD TRANSCRIPTION FACTORS; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNE TOLERANCE; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-17; INTERLEUKIN-33; INTERLEUKINS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MYELOID CELLS; NITRIC OXIDE SYNTHASE TYPE II; SKIN; SKIN TRANSPLANTATION; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH17 CELLS; TRANSPLANTATION, ISOGENEIC;

EID: 84938421937     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12483     Document Type: Article

References (29)

1. Chinen J, Buckley RH. Transplantation immunology: solid organ and bone marrow. J Allergy Clin Immunol 2010; 125:S324-35.
2. Rank MA, Kobayashi T, Kozaki H, Bartemes KR, Squillace DL, Kita H. IL-33-activated dendritic cells induce an atypical TH2-type response. J Allergy Clin Immunol 2009; 123:1047-54.
3. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005; 23:479-90.
4. Xu D, Jiang HR, Kewin P, Li Y, Mu R, Fraser AR et al. IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proc Natl Acad Sci USA 2008; 105:10913-8.
5. Spits H, Cupedo T. Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Annu Rev Immunol 2012; 30:647-75.
6. Jiang HR, Milovanovic M, Allan D, Niedbala W, Besnard AG, Fukada SY et al. IL-33 attenuates EAE by suppressing IL-17 and IFN-γ production and inducing alternatively activated macrophages. Eur J Immunol 2012; 42:1804-14.
7. + T cell responses. Science 2012; 335:984-9.
8. Mayuzumi N, Matsushima H, Takashima A. IL-33 promotes DC development in BM culture by triggering GM-CSF production. Eur J Immunol 2009; 39:3331-42.
9. Schiering C, Krausgruber T, Chomka A, Frohlich A, Adelmann K, Wohlfert EA et al. The alarmin IL-33 promotes regulatory T-cell function in the intestine. Nature 2014; 513:564-8.
10. + regulatory T cells. J Immunol. 2014; 15; 193:4010-20.
11. Brunner SM, Schiechl G, Falk W, Schlitt HJ, Geissler EK, Fichtner-Feigl S. Interleukin-33 prolongs allograft survival during chronic cardiac rejection. Transpl Int 2011; 24:1027-39.
12. + cells, and mediates Treg-dependent promotion of cardiac allograft survival. J Immunol 2011; 187:4598-610.
13. + regulatory T-cell responses in mice. Mol Med 2012; 18:753-61.
14. Yin H, Li X, Hu S, Liu T, Yuan B, Gu H et al. IL-33 accelerates cutaneous wound healing involved in upregulation of alternatively activated macrophages. Mol Immunol 2013; 56:347-53.
15. Villarreal DO, Weiner DB. Interleukin 33: a switch-hitting cytokine. Curr Opin Immunol 2014; 28:102-6.
16. Liu Q, Turnquist HR. Implications for interleukin-33 in solid organ transplantation. Cytokine 2013; 62:183-94.
17. + T cells phenotypic signature. Immunol Cell Biol 2015; 93:113-9.
18. Suzukawa M, Koketsu R, Iikura M, Nakae S, Matsumoto K, Nagase H et al. Interleukin-33 enhances adhesion, CD11b expression and survival in human eosinophils. Lab Invest 2008; 88:1245-53.
19. Pecaric-Petkovic T, Didichenko SA, Kaempfer S, Spiegl N, Dahinden CA. Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33. Blood 2009; 113:1526-34.
20. Cho KA, Suh JW, Sohn JH, Park JW, Lee H, Kang JL et al. IL-33 induces Th17-mediated airway inflammation via mast cells in ovalbumin-challenged mice. Am J Physiol Lung Cell Mol Physiol 2012; 302:L429-40.
21. + T and NK Cells. J Immunol 2015; 194:438-45.
22. Gabrilovich DI, Nagaraj S. Myeloid-derived-suppressor cells as regulators of the immune system. Nat Rev Immunol 2009; 9:162-74.
23. Youn JI, Gabrilovich DI. The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity. Eur J Immunol 2010; 40:2969-75.
24. Wood KJ, Goto R. Mechanisms of rejection: current perspectives. Transplantation 2012; 93:1-10.
25. + T cells. J Immunol. 2005; 174:3741-8.
26. Miller AM. Role of IL-33 in inflammation and disease. J Inflamm 2011; 8:22.
27. Wasserman A, Ben-Shoshan J, Entin-Meer M, Maysel-Auslender S, Guzner-Gur H, Keren G. Interleukin-33 augments Treg cell levels: a flaw mechanism in atherosclerosis. Isr Med Assoc J 2012; 14:620-3.
28. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003; 3:199-210.
29. Burrell BE, Nakayama Y, Xu J, Brinkman CC, Bromberg JS. Regulatory T cell induction, migration, and function in transplantation. J Immunol 2012; 189:4705-11.